Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical value of preoperative circulating tumor DNA before surgery in patients with esophageal squamous cell carcinoma.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology - 1 May 2025

Kobayashi Ryota, Matsuda Satoru, Nakamura Kohei, Kawakubo Hirofumi, Ho Keiso, Morimoto Yosuke, Hisaoka Kazuhiko, Hoshi Yuki, Takeuchi Masashi, Fukuda Kazumasa, Okui Jun, Nishihara Hiroshi, Kitagawa Yuko

Abstract excerpt

INTRODUCTION: A precise preoperative tumor monitoring method that reflects tumor burden during neoadjuvant treatment is required to guide individualized perioperative treatment strategies for esophageal squamous cell carcinoma (ESCC). This study examined the clinical significance of preoperative circulating tumor DNA (ctDNA) in the plasma of patients undergoing neoadjuvant chemotherapy (NAC) followed by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Squamous Cell
Share to Circulating Tumor DNA

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Esophageal Neoplasms

Share to Esophageal Squamous Cell Carcinoma

Share to Neoadjuvant Therapy

Share to Neoplasm Recurrence, Local

Share to Survival Rate

Source

Identifiers

PMID: 39862837
DOI: 10.1016/j.ejso.2025.109625

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical value of preoperative circulating tumor DNA before surgery in patients with esophageal squamous cell carcinoma.PMID 39862837Read ↗

Noninvasive diagnosis and monitoring of mutations by deep sequencing of circulating tumor DNA in esophageal squamous cell carcinoma.Semantic proximity Read ↗

Analysis of circulating tumor DNA to predict risk of recurrence in patients with esophageal and gastric cancersSemantic proximity Read ↗

A Review of Circulating Tumor DNA in the Diagnosis and Monitoring of Esophageal Cancer.Semantic proximity Read ↗

Next-Generation Sequencing of Plasma Cell-Free DNA for Treatment Monitoring in Advanced Head and Neck Cancer Patients.Semantic proximity Read ↗

Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancer.Semantic proximity Read ↗

Frequent tumor burden monitoring of esophageal squamous cell carcinoma with circulating tumor DNA using individually designed digital PCRSemantic proximity Read ↗

Potential Clinical Utility of a Targeted Circulating Tumor DNA Assay in Esophageal Adenocarcinoma.Semantic proximity Read ↗

Gene-specific ctDNA dynamics predict tumour burden and survival outcomes in ESCC: A prospective cohort study.Semantic proximity Read ↗

Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer.Semantic proximity Read ↗

Serial Circulating Tumor DNA in Predicting and Monitoring the Effect of Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer: A Prospective Multicenter Study.Semantic proximity Read ↗

Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.Semantic proximity Read ↗

Deciphering molecular relapse and intra-tumor heterogeneity in non-metastatic resectable head and neck squamous cell carcinoma using circulating tumor DNA.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.